Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in Portugal

This is an epidemiological study to assess the the prevalence of Age-Related Macular (ARM) Degeneration in Portugal.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age-Related Macular Degeneration Eye Diseases Macular Degeneration Retinal Degeneration Retinal Diseases

Age range

55 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Health care units of Lousã and Trevim-Sol, Lousã, Coimbra District, Portugal

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Participants with 55 years-old

Exclusion criteria

None

Treatment and study plan

Primary outcomes

ARM

Time frame: 1 month after the screening

Signs of Age-Related Macular Degeneration

Secondary outcomes

Other ocular disease

Time frame: 1 month after screening

Signs of other ocular disease such as: diabetic retinopathy, glaucoma, cataract, etc.

Sponsors and collaborators

Lead sponsor

Association for Innovation and Biomedical Research on Light and Image

Other

Registry information

Important dates

Study start: 2009
Primary completion: 2013
Study completion: 2013
First posted: Feb 18, 2011
Registry last updated: Jan 5, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed